A novel angiographic index for predicting the efficacy of drug-coated balloons in small vessels

Angiographically derived RWS has the potential to predict the angiographic and clinical outcomes of DCB treatment for de novo SVD (PEPCAD China SVD study; ClinicalTrials.gov: NCT03625830).